itci

Health Care Sector Update for 12/23/2015: EYG, ITCI

Top Health-care stocks:

JNJ: +0.6%

PFE: +0.4%

ABT: flat

MRK: flat

AMGN: flat

Health-care shares were mainly unchanged in pre-market trade on Wednesday.

In health-care stocks news, Eyegate Pharmaceuticals ( EYEG ) shares were initiated by Chardan with a buy rating and price target of $6 per share.

Shares in the company were unchanged at $2.50 pre-bell. This is within the lower band of the stock's 52 week trading range between $2.39 and $27.

And Intra-Cellular Therapies ( ITCI ) announced that it has started enrollment for the Phase 3 clinical trials in its bipolar depression program.

Shares in the company were flat at $52.66. This is within the upper band of the stock's 52 week trading range between $16.27 and $60.79.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.